Richard A. Edlin, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), bought 6,000 shares at $79.44 ($477K) on 2017-03-22, disclosed to the SEC on 2017-03-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.